Executive Director, Global HEOR - Cell Therapy,

Bristol Myers SquibbPrinceton, NJ
Hybrid

About The Position

Bristol Myers Squibb is seeking a motivated, adaptable, inclusive, and decisive Executive Director, Global HEOR - Cell Therapy. This role requires strong leadership focused on building alignment, fostering collaborations, and enabling a high-performing, globally integrated team. The position demands deep expertise in health economics and outcomes research (HEOR), a comprehensive understanding of global market access, and the ability to translate complex clinical, real-world, and economic evidence into actionable strategies for senior leadership. The Executive Director will lead the integrated evidence generation and value demonstration strategy for the Cell Therapy portfolio, ensuring alignment with market access, commercial, medical, and regulatory priorities. A key focus is advancing enterprise-level real-world evidence (RWE) capabilities, including linking registry data with claims and EHR datasets for differentiated insights. In partnership with Global Market Access, Pricing, Policy, Medical Affairs, and Commercial leadership, this role will shape evidence strategies for the evolving access landscape of cell therapies, addressing structural challenges like site-of-care economics, provider adoption, and reimbursement pathways. The role also emphasizes talent development and team empowerment.

Requirements

  • Advanced degree (PhD, PharmD, MPH, MS) in health economics, epidemiology, public health, or related field.
  • Minimum of 10 to 15 years’ experience with a strong track record in HEOR, or real-world evidence generation in the pharmaceutical industry.
  • Significant experience in HEOR, including study design and execution in real-world evidence (RWE), economic modeling, patient-reported outcomes (PROs), and HTA strategy.
  • Proven track record of leading integrated evidence strategies for complex or specialty therapeutic areas (Cell Therapy experience preferred).
  • Strong understanding of global market access environments, including US payer and ex-US HTA requirements.
  • Demonstrated ability to translate complex data into clear, decision-ready insights for senior leadership and external stakeholders.
  • Experience influencing regulatory submissions, HTA engagements, and scientific publications/presentations.
  • Proven leadership in cross-functional collaboration across Market Access, Medical, Commercial, Regulatory, and Policy.
  • Experience advancing innovative data platforms (e.g., registry, claims, and EHR integration).
  • Strong people leadership capabilities, with experience building and developing high-performing, inclusive teams.
  • Strategic mindset with the ability to balance near-term execution and long-term value demonstration priorities.

Nice To Haves

  • Cell Therapy experience preferred

Responsibilities

  • Set and lead global HEOR and integrated evidence strategy across the lifecycle of Cell Therapy assets.
  • Define and drive the HEOR vision and evidence generation strategy across the full lifecycle of Cell Therapy assets, ensuring alignment with product strategy, market access, and commercialization priorities.
  • Deliver end-to-end evidence generation and value demonstration and oversee the design, execution, and dissemination of HEOR studies.
  • Advance innovative data and RWE capabilities by leading development and application of advanced data platforms.
  • Translate evidence into access, pricing, and value strategy and embed HEOR into cross-functional decision-making.
  • Shape compelling value propositions and ensure evidence is effectively translated into strategies that inform pricing, reimbursement, and global access decisions.
  • Partner with Market Access, Medical, Commercial, Regulatory, and Policy teams to integrate HEOR into brand planning, integrated evidence plans, and lifecycle strategy execution.
  • Develop evidence strategies supporting Cell Therapy class expansion and broader adoption.
  • Drive external engagement and scientific leadership, including thought leader partnerships.
  • Lead HEOR publication strategy, congress presentations, and strategic engagement with external thought leaders.
  • Build, develop, and lead a high-performing global HEOR team.
  • Identify and develop top talent, foster an inclusive and high-performance culture, and lead a globally distributed high performing team.
  • Develop and maintain up-to-date knowledge for training of new and existing team members and upskill team members as business priorities change.
  • Cultivate a culture of continuous learning and innovation by empowering teams with internal rotations.
  • Own portfolio prioritization, operations, and evidence gap closure.
  • Manage portfolio-level prioritization, budgets, and execution of the HEOR book of work; define and address critical evidence gaps.

Benefits

  • Health Coverage: Medical, pharmacy, dental, and vision care.
  • Wellbeing Support: Programs such as BMS Well-Being Account, BMS Living Life Better, and Employee Assistance Programs (EAP).
  • Financial Well-being and Protection: 401(k) plan, short- and long-term disability, life insurance, accident insurance, supplemental health insurance, business travel protection, personal liability protection, identity theft benefit, legal support, and survivor support.
  • Work-life benefits include: Paid Time Off US Exempt Employees: flexible time off (unlimited, with manager approval, 11 paid national holidays (not applicable to employees in Phoenix, AZ, Puerto Rico or Rayzebio employees))
  • Phoenix, AZ, Puerto Rico and Rayzebio Exempt, Non-Exempt, Hourly Employees: 160 hours annual paid vacation for new hires with manager approval, 11 national holidays, and 3 optional holidays
  • Based on eligibility, additional time off for employees may include unlimited paid sick time, up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence for medical, personal, parental, caregiver, bereavement, and military needs and an annual Global Shutdown between Christmas and New Years Day.
  • All global employees full and part-time who are actively employed at and paid directly by BMS at the end of the calendar year are eligible to take advantage of the Global Shutdown.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service